AMEX · Medical - Devices

XTNT (XTNT) Stock

$0.43 +1.45% AMEX: XTNT Healthcare

Valuation

MetricValue
Price$0.43
Market Cap$60.65M
P/E Ratio15.67
P/B Ratio1.28
P/S Ratio0.54
EPS (TTM)$0.03
52-Week High$0.95
52-Week Low$0.39
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE9.80%
ROA5.32%
ROCE13.73%
Gross Margin5.22%
Operating Margin5.22%
Net Margin1.50%
Debt/Equity0.32
Current Ratio2.69

Annual Financials (USD)

Metric20212022202320242025
Revenue$55.0M$58.0M$91.0M$117.0M$134.0M
Operating Profit$-4.0M$-7.0M$-10.0M$-12.0M$7.0M
Net Profit$-5.0M$-8.0M$1.0M$-16.0M$5.0M
EPS$-0.06$-0.09$0.01$-0.12$0.03
Op Margin-7.0%-11.7%-11.1%-10.3%5.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$55.0M$60.0M$93.0M$94.0M$94.0M
Total Liabilities$24.0M$26.0M$41.0M$51.0M$43.0M
Cash$18.0M$20.0M$6.0M$6.0M$17.0M
Borrowings$17.0M$17.0M$24.0M$35.0M$29.0M

Latest News

Xtant Medical Q1 Earnings Call Highlights MarketBeat · May 16, 2026 Xtant Medical Holdings, Inc. Q1 2026 Earnings Call Summary Moby · May 14, 2026 Xtant Medical Holdings Inc (XTNT) Q1 2026 Earnings Call Highlights: Navigating Challenges and ... GuruFocus.com · May 13, 2026 Xtant Medical Hldgs Q1 2026 Earnings Call Transcript Benzinga · May 13, 2026 Xtant Medical Reports First Quarter 2026 Financial Results PR Newswire · May 13, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$-5.0M$-10.0M$-12.0M$13.0M
Investing Cash Flow$-4.0M$-3.0M$-26.0M$-8.0M$6.0M
Financing Cash Flow$0$0$0$-1.0M$0
Net Cash Flow$16.0M$2.0M$-15.0M$0$11.0M
Free Cash Flow$-2.0M$-7.0M$-11.0M$-16.0M$10.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA6.44
FCF Yield11.91%
Quick Ratio1.64
Interest Coverage1.75
Return 1Y-28.23%
Return 3Y-50.00%
Return 5Y-65.50%

Ownership

Insiders Held13.84%
Institutions Held57.33%
Institutions Float Held66.54%
Institutional HolderSharesReport Date
Nantahala Capital Management, LLC68,394,0002026-03-31
AWM Investment Company, Inc.5,976,9102026-03-31
Vanguard Capital Management LLC2,014,6032026-03-31
Renaissance Technologies, LLC987,4102026-03-31
Geode Capital Management, LLC529,2142026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
APYX $4.07 -1.21% -17.90 $171.39M 0.00%
ESLAEstrella Immunopharma, Inc. $0.78 +0.06% -2.25 $33.59M 0.00%
EXOZ $4.65 +1.09% -8.62 $43.16M 0.00%
FONR $19.09 +0.00% 15.33 $117.76M 0.00%
LUCD $0.97 +1.47% -1.45 $98.94M 0.00%

About XTNT

XTNT is led by CEO Sean E. Browne, employs 217 people, headquartered in US, publicly traded since 2010.

XTNT stock trades at $0.43 with a market capitalization of $60.65M. The stock is valued at a price-to-earnings (P/E) ratio of 15.67, price-to-book of 1.28, price-to-sales of 0.54. Over the past 52 weeks the stock has ranged between $0.39 and $0.95, and currently trades 54.7% below its 52-week high.

On profitability, XTNT generates a return on equity (ROE) of 9.80%, return on capital employed of 13.73%, an operating margin of 5.22%, a net profit margin of 1.50%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides